Ovid Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD | 05/12/2025 | 7.53 M | $2.35 B | 0.00% | 6.03% |
| RUBRIC CAPITAL MANAGEMENT LP | 05/14/2025 | 5.32 M | $1.66 M | 0.00% | 4.25% |
| BLACKROCK, INC. | 05/02/2025 | 3.86 M | $1.20 M | -1.76% | 3.09% |
| BVF INC/IL | 05/15/2025 | 3.85 M | $1.20 M | 0.00% | 3.08% |
| VANGUARD GROUP INC | 05/09/2025 | 3.11 M | $969.94 K | -1.25% | 2.49% |
| MADISON AVENUE PARTNERS, LP | 05/15/2025 | 2.47 M | $769.03 K | -33.77% | 1.97% |
| SIO CAPITAL MANAGEMENT, LLC | 05/15/2025 | 2.23 M | $696.16 K | 123.20% | 1.79% |
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 2.09 M | $650.00 K | 12.83% | 1.67% |
| KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2025 | 1.73 M | $540.48 K | 12.13% | 1.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.40 M | $436.72 K | 0.00% | 1.12% |
| STATE STREET CORP | 05/15/2025 | 1.37 M | $427.96 K | -1.61% | 1.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.33 M | $415.19 K | 0.12% | 1.06% |
| JPMORGAN CHASE & CO | 05/12/2025 | 1.21 M | $376.97 K | -14.78% | 0.97% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 1.15 M | $358.69 K | 15.00% | 0.92% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 1.02 M | $319.32 K | 850.60% | 0.82% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 786.55 K | $245.32 K | 5.75% | 0.63% |
| TLS ADVISORS LLC | 05/12/2025 | 680.97 K | $213.00 K | 0.00% | 0.54% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2025 | 667.52 K | $208.20 K | 100.00% | 0.53% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 560.83 K | $174.92 K | 699.88% | 0.45% |
| GSA CAPITAL PARTNERS LLP | 05/08/2025 | 440.10 K | $137.00 K | 256.12% | 0.35% |
| NORTHERN TRUST CORP | 05/13/2025 | 423.62 K | $132.13 K | -13.22% | 0.34% |
| CITADEL ADVISORS LLC | 05/15/2025 | 367.97 K | $114.77 K | 4,834.61% | 0.29% |
| SQUAREPOINT OPS LLC | 05/15/2025 | 265.49 K | $82.81 K | 100.00% | 0.21% |
| VERITION FUND MANAGEMENT LLC | 05/15/2025 | 215.06 K | $67.08 K | 46.00% | 0.17% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 200.59 K | $62.57 K | -31.23% | 0.16% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 165.76 K | $51.70 K | 0.00% | 0.13% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 135.49 K | $42.26 K | -16.27% | 0.11% |
| 05/12/2025 | 119.11 K | $37.15 K | 100.00% | 0.10% | |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 115.87 K | $36.14 K | -11.23% | 0.09% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 105.18 K | $32.61 K | 0.00% | 0.08% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 104.44 K | $32.57 K | -47.29% | 0.08% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2025 | 97.00 K | $30.25 K | 38.57% | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 95.43 K | $29.77 K | -58.35% | 0.08% |
| XTX TOPCO LTD | 05/08/2025 | 93.15 K | $29.06 K | 100.00% | 0.07% |
| EMPOWERED FUNDS, LLC | 05/16/2025 | 91.23 K | $28.46 K | -34.09% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 83.08 K | $25.91 K | 84.14% | 0.07% |
| MORGAN STANLEY | 05/15/2025 | 82.73 K | $25.80 K | -56.34% | 0.07% |
| RHUMBLINE ADVISERS | 05/29/2025 | 80.92 K | $25.24 K | -3.76% | 0.06% |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 66.95 K | $20.88 K | -36.06% | 0.05% |
| BARCLAYS PLC | 05/15/2025 | 63.92 K | $19.00 K | -31.50% | 0.05% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 47.78 K | $14.90 K | 0.00% | 0.04% |
| INTECH INVESTMENT MANAGEMENT LLC | 05/20/2025 | 44.01 K | $13.73 K | 85.51% | 0.04% |
| CITIGROUP INC | 05/12/2025 | 43.20 K | $13.47 K | -11.03% | 0.03% |
| SG AMERICAS SECURITIES, LLC | 04/15/2025 | 43.03 K | $13.00 K | 14.33% | 0.03% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 37.01 K | $11.54 K | 4.17% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 31.75 K | $9.87 K | -44.04% | 0.03% |
| FMR LLC | 05/12/2025 | 30.90 K | $9.64 K | -11.51% | 0.02% |
| COREBRIDGE FINANCIAL, INC. | 05/14/2025 | 28.85 K | $9.00 K | -1.46% | 0.02% |
| INVESCO LTD. | 05/12/2025 | 27.21 K | $8.49 K | 0.00% | 0.02% |
| FIRST MANHATTAN CO. LLC. | 05/15/2025 | 26.00 K | $8.11 K | 0.00% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ovid Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 99 institutional investors and hedge funds held shares of Ovid Therapeutics Inc.. The most heavily invested institutionals were:
TAKEDA PHARMACEUTICAL CO LTD: 7.53 M
Rubric Capital Management LP: 5.32 M
BlackRock, Inc.: 3.86 M
BVF INC/IL: 3.85 M
VANGUARD GROUP INC: 3.11 M
Madison Avenue Partners, LP: 2.47 M
37.12% of Ovid Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 52.45 M shares in the last 24 months. This purchase volume represents approximately $14.28 M in transactions.